MaxCyte(MXCT) - 2025 Q4 - Earnings Call Transcript
2026-03-24 21:30
MaxCyte (NasdaqGS:MXCT) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Speaker8Please note, this conference is being recorded. Now we'll turn the call over to Erik Abdo with Investor Relations. Please proceed.Speaker3Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MaxCyte, we have Maher Masoud, President and Chief Executive Officer, Douglas Swirsky, Chief Financial Officer, and Sean Menarguez, Senior Director of Business Development. Earlier to ...
Lantronix (NasdaqCM:LTRX) FY Conference Transcript
2026-03-24 21:02
Lantronix (NasdaqCM:LTRX) FY Conference March 24, 2026 04:00 PM ET Company ParticipantsSaleel Awsare - CEOConference Call ParticipantsScott Searle - Managing Director and Senior Research AnalystScott SearleThank you for joining us for this fireside chat as we enter the afternoon, the last day of the 38th Annual Roth Conference. I'm Scott Searle. I'm the communications AIoT and Edge Compute Analyst with Roth. What we try to do in our fireside chats are identify and highlight companies where there's something ...
AAR(AIR) - 2026 Q3 - Earnings Call Presentation
2026-03-24 21:00
Third Quarter Fiscal Year 2026 Earnings Call March 24, 2026 This presentation contains certain statements relating to future results, which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, which reflect management's expectations about future conditions, including, but not limited to, our fourth quarter and full year FY2026 guidance, continued demand in the commercial and government aviation markets, anticipated activities and benefits under exte ...
KB Home(KBH) - 2026 Q1 - Earnings Call Presentation
2026-03-24 21:00
Presentation Investor First Quarter 2026 1 1957 BUILT OVER 700K HOMES SINCE OUR FOUNDING IN 1957 Leading brand awareness Forward-Looking Statements BTO DIFFERENTIATED BUILT TO ORDER® MODEL 2 Certain matters discussed in this press release, including any statements that are predictive in nature or concern future market and economic conditions, business and prospects, our future financial and operational performance, or our future actions and their expected results are "forward-looking statements" within the ...
Inseego (NasdaqGS:INSG) FY Conference Transcript
2026-03-24 20:32
Inseego (NasdaqGS:INSG) FY Conference March 24, 2026 03:30 PM ET Company ParticipantsJuho Sarvikas - President and CEOConference Call ParticipantsScott Searle - Communications, AIoT, and Edge Compute AnalystScott SearleHey, good afternoon. Thank you so much for joining us at Fireside Chat on the second afternoon, Tuesday afternoon of the 38th Annual Roth Conference. I'm Scott Searle. I'm the communications, AIoT, and edge compute analyst with Roth. What we try to do in our Fireside Chats are identify compan ...
Braze(BRZE) - 2026 Q4 - Earnings Call Presentation
2026-03-24 20:30
Q4 Fiscal 2026 Earnings Results March 24, 2026 Braze Financial Highlights $821M QUARTERLY REVENUE RUN RATE 1 28% YoY REVENUE GROWTH 2,609 CUSTOMERS IN OVER 85 COUNTRIES DOLLAR-BASED NET RETENTION 109% RATE 94% SUBSCRIPTION $32M GAAP NET LOSS Data as of January 31, 2026 or the three months ended, as applicable 1. Represents quarterly GAAP revenue multiplied by 4 2 REVENUE Forward Looking Statements and Disclaimers Forward-Looking Statements This presentation contains, and statements made during this presenta ...
Arm (NasdaqGS:ARM) Conference Transcript
2026-03-24 20:17
Arm (NasdaqGS:ARM) Conference March 24, 2026 03:15 PM ET Company ParticipantsAmi Badani - CMOAndrew Gardiner - Head of European Technology Equity ResearchChris Bergey - EVP of Edge AIDrew Henry - EVP of Physical AIEric Hayes - EVP of OperationsHarlan Sur - Executive Director of Equity ResearchIan Thornton - VP of Investor RelationsJason Child - EVP and CFOMark Lipacis - Senior Managing DirectorMohamed Awad - EVP of Cloud AIRene Haas - CEORoss Seymore - Managing DirectorSharbani Roy - VP of AI ServicesVictor ...
Moleculin Biotech (NasdaqCM:MBRX) FY Conference Transcript
2026-03-24 20:02
Moleculin Biotech (NasdaqCM:MBRX) FY Conference March 24, 2026 03:00 PM ET Company ParticipantsWalter Klemp - Founder, Chairman, and CEOConference Call ParticipantsJonathan Aschoff - Senior Biotechnology AnalystJonathan AschoffWelcome back. This is Jonathan Aschoff, senior biotechnology analyst at Roth Capital Partners. Who we have now is Walter Klemp, the CEO of Moleculin Biotech.Walter KlempHey, Jonathan.Jonathan AschoffUm-Walter KlempThanks for having me.Jonathan AschoffYou're very welcome, Wally. You kn ...
Vantage (NYSEAM:VNTG) Earnings Call Presentation
2026-03-24 20:00
Vantage Corp Investor Presentation NYSEAM: VNTG March 2026 Forward Looking Statement This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the intended use of the proceeds. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "anticipate", "estimate", "expect ...
Biostem Technologies (OTCPK:BSEM) Earnings Call Presentation
2026-03-24 20:00
Company Presentation MARCH 2026 Forward Looking Statements Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. The following is a list of risks, among others, that could cause actual results to differ materially from those contemplated by the forward-looki ...